Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2009 1
2010 1
2011 1
2012 1
2014 4
2015 1
2016 3
2017 1
2018 3
2020 2
2021 1
2022 2
2023 6
2024 4
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression.
Vasalou C, Proia TA, Kazlauskas L, Przybyla A, Sung M, Mamidi S, Maratea K, Griffin M, Sargeant R, Urosevic J, Rosenbaum AI, Yuan J, Aluri KC, Ramsden D, Hariparsad N, Jones RDO, Mettetal JT. Vasalou C, et al. Among authors: urosevic j. CPT Pharmacometrics Syst Pharmacol. 2024 Jun;13(6):994-1005. doi: 10.1002/psp4.13133. Epub 2024 Mar 26. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38532525 Free PMC article.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Lawson M, Cureton N, Ros S, Cheraghchi-Bashi A, Urosevic J, D'Arcy S, Delpuech O, DuPont M, Fisher DI, Gangl ET, Lewis H, Trueman D, Wali N, Williamson SC, Moss J, Montaudon E, Derrien H, Marangoni E, Miragaia RJ, Gagrica S, Morentin-Gutierrez P, Moss TA, Maglennon G, Sutton D, Polanski R, Rosen A, Cairns J, Zhang P, Sánchez-Guixé M, Serra V, Critchlow SE, Scott JS, Lindemann JPO, Barry ST, Klinowska T, Morrow CJ, Carnevalli LS. Lawson M, et al. Among authors: urosevic j. Cancer Res. 2023 Dec 1;83(23):3989-4004. doi: 10.1158/0008-5472.CAN-23-0694. Cancer Res. 2023. PMID: 37725704 Free PMC article.
Organ-specific metastases.
Urosevic J, Gomis RR. Urosevic J, et al. Nat Biomed Eng. 2018 Jun;2(6):347-348. doi: 10.1038/s41551-018-0249-3. Nat Biomed Eng. 2018. PMID: 31011192 No abstract available.
The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells.
Criscione SW, Martin MJ, Oien DB, Gorthi A, Miragaia RJ, Zhang J, Chen H, Karl DL, Mendler K, Markovets A, Gagrica S, Delpuech O, Dry JR, Grondine M, Hattersley MM, Urosevic J, Floc'h N, Drew L, Yao Y, Smith PD. Criscione SW, et al. Among authors: urosevic j. NPJ Precis Oncol. 2022 Dec 27;6(1):95. doi: 10.1038/s41698-022-00337-w. NPJ Precis Oncol. 2022. PMID: 36575215 Free PMC article.
Cancer monitoring methods.
Nikolic A, Botrugno OA, Urosevic J, Tosic N. Nikolic A, et al. Among authors: urosevic j. Biomed Res Int. 2014;2014:981495. doi: 10.1155/2014/981495. Epub 2014 Apr 3. Biomed Res Int. 2014. PMID: 24804266 Free PMC article. No abstract available.
MAPK signaling control of colon cancer metastasis.
Urosevic J, Nebreda AR, Gomis RR. Urosevic J, et al. Cell Cycle. 2014;13(17):2641-2. doi: 10.4161/15384101.2014.946374. Cell Cycle. 2014. PMID: 25486343 Free PMC article. No abstract available.
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.
Vora S, Chatterjee S, Andrew A, Kumar RP, Proctor M, Zeng Z, Bhatt R, Nazareth D, Fernando M, Jones MJK, He Y, Hooper JD, McMillan NAJ, Urosevic J, Saeh J, Travers J, Cimini D, Chen J, Gabrielli B. Vora S, et al. Among authors: urosevic j. Cell Death Dis. 2025 Jan 8;16(1):7. doi: 10.1038/s41419-024-07329-7. Cell Death Dis. 2025. PMID: 39779678 Free PMC article.
Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B, Urosevic J, Mertens C, Mora J, Guiu M, Gomis RR, Weigert A, Schmid T, Grein S, Brüne B, Jung M. Ören B, et al. Among authors: urosevic j. J Pathol. 2016 Jul;239(3):274-85. doi: 10.1002/path.4724. Epub 2016 Apr 29. J Pathol. 2016. PMID: 27038000
Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors.
Chou DB, Furlong BA, Posey RR, Kyprianou C, O'Sullivan LR, David R, Randle SJ, Polanska UM, Travers J, Urosevic J, Hutchinson JN, Che J, Howley AM, Hasserjian RP, Prantil-Baun R, Ingber DE. Chou DB, et al. Among authors: urosevic j. Nat Commun. 2022 Oct 12;13(1):6021. doi: 10.1038/s41467-022-33672-4. Nat Commun. 2022. PMID: 36224199 Free PMC article.
34 results